Purpose. Women who undergo a benign breast biopsy are at elevated risk for
the subsequent development of breast cancer (BC). Therefore, appropriate cl
inical follow-up of a benign breast biopsy is important. The present study
examines the extent and correlates of nonadherence with follow-up recommend
ations after a benign breast biopsy.
Methods. Women (n = 114) who had undergone a benign breast biopsy completed
an initial telephone interview within 50 days of their biopsy (mean = 21 d
ays). Additional telephone interviews were completed at 4 and 8 months post
-biopsy. Measures of BC risk perception, general and BC-specific distress,
BC-related attitudes and beliefs, social support, optimism, and information
al coping style were completed. Specific recommendations for clinical follo
w-up and evidence of actual follow-up were obtained from medical records.
Results. Of 103 women given a specific recommendation for clinical follow-u
p, 34% were classified as nonadherent with follow-up recommendations. Logis
tic regression analyses indicated that nonadherent women were characterized
by younger age, recommendations for follow-up by clinical breast examinati
on alone, greater confidence in their ability to perform breast self-examin
ation properly, higher perceived personal risk for BC, and greater BC-speci
fic distress.
Conclusion. Despite the importance of appropriate clinical follow-up of a b
enign breast biopsy, about one-third of women did not adhere to recommended
follow-up. Risk factors for nonadherence suggest potential avenues for int
erventions to enhance participation in appropriate clinical follow-up.